BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38175343)

  • 1. Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.
    Giunta EF; Arrichiello G; Pappalardo A; Federico P; Petrillo A
    Cancer Treat Res; 2023; 188():89-104. PubMed ID: 38175343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline E-cadherin mutations in familial lobular breast cancer.
    Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
    J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 germline mutations in families with hereditary lobular breast cancer.
    Girardi A; Magnoni F; Vicini E; Kouloura A; La Vecchia C; Veronesi P; Corso G
    Eur J Cancer Prev; 2022 May; 31(3):274-278. PubMed ID: 33990097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
    Corso G; Figueiredo J; La Vecchia C; Veronesi P; Pravettoni G; Macis D; Karam R; Lo Gullo R; Provenzano E; Toesca A; Mazzocco K; Carneiro F; Seruca R; Melo S; Schmitt F; Roviello F; De Scalzi AM; Intra M; Feroce I; De Camilli E; Villardita MG; Trentin C; De Lorenzi F; Bonanni B; Galimberti V
    J Med Genet; 2018 Jul; 55(7):431-441. PubMed ID: 29929997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
    Keller G; Vogelsang H; Becker I; Hutter J; Ott K; Candidus S; Grundei T; Becker KF; Mueller J; Siewert JR; Höfler H
    Am J Pathol; 1999 Aug; 155(2):337-42. PubMed ID: 10433926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Diffuse Gastric Cancer: Approaches to Screening, Surveillance, and Treatment.
    Pilonis ND; Tischkowitz M; Fitzgerald RC; di Pietro M
    Annu Rev Med; 2021 Jan; 72():263-280. PubMed ID: 33217247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing by cancer site: stomach.
    Chun N; Ford JM
    Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin germline mutation carriers: clinical management and genetic implications.
    Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
    Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 germline mutations and hereditary lobular breast cancer.
    Corso G; Intra M; Trentin C; Veronesi P; Galimberti V
    Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cate's Story: Hereditary Diffuse Gastric Cancer.
    Rogers M
    Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.
    Treese C; Siegmund B; Daum S
    Curr Oncol; 2022 Mar; 29(4):2454-2460. PubMed ID: 35448173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
    Shenoy S
    Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
    Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
    J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.